GUERINI ROCCO, ELENA

GUERINI ROCCO, ELENA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 106 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Concurrent presence of primary hemangioma and breast cancer metastasis within a lymph node: a case report inspired by the legacy of Professor Juan Rosai 2024 Frascarelli C.Guerini-Rocco E.Fusco N. + Article (author) -
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review 2024 Giuseppe CarusoGiovanni AlettiElena Guerini-RoccoAndrea Mariani + Article (author) -
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer 2024 Guerini-Rocco E.Venetis K.Cursano G.Frascarelli C.Negrelli M.Olmeda E.Trapani D.Criscitiello C.Curigliano G.Fusco N. + Article (author) -
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores 2024 Frascarelli C.Venetis K.Sajjadi E.Criscitiello C.Curigliano G.Guerini-Rocco E.Fusco N. + Article (author) -
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype 2024 Corso, GiovanniMassari, GiuliaSajjadi, ElhamPesapane, FilippoNicosia, LucaLa Vecchia, CarloGuerini-Rocco, ElenaVeronesi, Paolo + Article (author) -
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy 2024 Venetis K.Pescia C.Cursano G.Frascarelli C.Criscitiello C.Curigliano G.Guerini Rocco E.Fusco N. + Article (author) -
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 2023 Nicola FuscoChiara FrascarelliCarmen CriscitielloElham SajjadiKonstantinos VenetisGiuseppe CuriglianoElena Guerini-Rocco + Article (author) -
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking 2023 Chiara FrascarelliElena Guerini RoccoNicola Fusco + Article (author) -
Pathology and Somatic Alterations in Hereditary Lobular Breast Cancers 2023 Fusco N.Guerini-Rocco E. + Book Part (author) -
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management 2023 Francesca Maria PortaFederica GiuglianoChiara FrascarelliElham SajjadiKonstantinos VenetisElena Guerini-RoccoGiuseppe CuriglianoCarmen CriscitielloNicola Fusco + Article (author) -
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies 2023 Carlo PesciaElena Guerini-RoccoGiuseppe VialeNicola Fusco Article (author) -
Trop-2 as an Actionable Biomarker in Breast Cancer 2023 Emanuele FrigoElham SajjadiKonstantinos VenetisElena Guerini-RoccoCarmen CriscitielloGiuseppe CuriglianoNicola Fusco + Article (author) -
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test 2023 Sajjadi E.Guerini-Rocco E.Venetis K.Fusco N. + Article (author) -
In-house homologous recombination deficiency testing in ovarian cancer: A multi-institutional Italian pilot study 2023 Guerini-Rocco E.Fusco N.Venetis K. + Article (author) -
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene 2023 Corso G.Calvello M.Veronesi P.Guerini-Rocco E. + Article (author) -
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods 2023 Sajjadi E.Venetis K.Frascarelli C.Cursano G.Guerini-Rocco E.Fusco N. + Article (author) -
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis 2023 Sajjadi E.Venetis K.Ferrero S.Veronesi P.Viale G.Fusco N.Guerini-Rocco E. + Article (author) -
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 2022 Venetis K.Sajjadi E.Viale G.Guerini-Rocco E.Fusco N. + Article (author) -
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 2022 Rocco E. G.Viale G. + Article (author) -
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes 2022 Konstantinos VenetisElena Guerini-RoccoNicola Fusco + Article (author) -